Month: <span>September 2021</span>

Home / 2021 / September
Post

Blood pressure rising at night linked to doubling risk of death in adults with diabetes

DALLAS, Sept. 27, 2021 — Adults with type 1 or type 2 diabetes whose blood pressure increased at night had more than double the risk of dying compared to those whose blood pressure “dipped” during sleep, according to a 21-year study presented today at the American Heart Association’s Hypertension Scientific Sessions 2021. The meeting is the...

Healthy changes in diet, activity improved treatment-resistant high blood pressure
Post

Healthy changes in diet, activity improved treatment-resistant high blood pressure

by  American Heart Association Credit: CC0 Public Domain People with treatment-resistant hypertension successfully reduced their blood pressure by adopting the Dietary Approaches to Stop Hypertension (DASH) eating plan, losing weight and improving their aerobic fitness by participating in a structured diet and exercise program at a certified cardiac rehabilitation facility, according to new research published today...

US has enough COVID-19 vaccines for boosters, kids’ shots
Post

US has enough COVID-19 vaccines for boosters, kids’ shots

by Todd Richmond and Kathleen Foody  In this Aug. 28, 2021, file photo, Mayra Navarrete, 13, receives the Pfizer COVID-19 vaccine from registered nurse, Noleen Nobleza at a clinic set up in the parking lot of CalOptima in Orange, Calif. With more than 40 million doses of coronavirus vaccines available, U.S. health authorities said they’re confident both...

Some chemotherapy side effects caused by single mutation could be prevented
Post

Some chemotherapy side effects caused by single mutation could be prevented

by Will Doss,  Northwestern University Graphical abstract. Credit: DOI: 10.1016/j.stem.2021.08.006 Harmful side effects from a common chemotherapy drug could be the result of a single mutation, according to a study published in Cell Stem Cell. The cardiotoxic effects of the chemotherapy drug doxorubicin could be prevented in patients with the mutation by treating them with retinoic acid,...

Cryolipolysis can do the opposite of what’s promised
Post

Cryolipolysis can do the opposite of what’s promised

by Michael Freeman,  The Conversation Cryolipolysis treatment leaves initial redness, but then fat is meant to shrink over subsequent months. Credit: Shutterstock At the height of her fame in the 1990s, supermodel Linda Evangelista was often quoted as saying she wouldn’t get out of bed for less than $10,000 a day. Now she’s revealed a popular cosmetic procedure has sent...

Honey can help kids who’ve swallowed a button battery
Post

Honey can help kids who’ve swallowed a button battery

by  Canadian Medical Association Journal Credit: Pixabay/CC0 Public Domain Button batteries are commonly used in many electronic devices, and the number of children ingesting button batteries is increasing, according to US data. A Five things to Know About… practice article in CMAJ (Canadian Medical Association Journal) highlights some key points for managing button battery ingestion. Injuries from battery...

How bad are carbs, really?
Post

How bad are carbs, really?

There is a fear that carbohydrates are detrimental to health. As a result, low carb diets have become popular, especially for weight loss. In this Honest Nutrition feature, we explain what carbohydrates are, look at healthy vs. unhealthy options, and discuss whether a diet rich in carbs is actually harmful.Written by Amber Charles, MSPH, RDN on September...

Post

Alternative to using race in kidney function test found

KAISER PERMANENTE OAKLAND, Calif. — Researchers have identified an approach to remove race from equations used to estimate a person’s kidney function. These equations have been criticized for potentially perpetuating racial health disparities. The findings, reported September 23 in the New England Journal of Medicine, are expected to inform National Kidney Foundation–American Society of Nephrology Task Force...

First biosimilar approved for macular degeneration, other eye conditions
Post

First biosimilar approved for macular degeneration, other eye conditions

(HealthDay)—The first biosimilar to Lucentis (ranibizumab injection) has been approved for the treatment of neovascular (wet) age-related macular degeneration and other eye diseases and conditions, the U.S. Food and Drug Administration announced Friday. The approval of the biosimilar, Byooviz (ranibizumab-nuna), is also indicated to treat macular edema after retinal vein occlusion and myopic choroidal neovascularization. Byooviz is...

Breast cancer researchers learn how to teach an old drug new tricks to help patients
Post

Breast cancer researchers learn how to teach an old drug new tricks to help patients

by Chris Malina,  University of Wisconsin-Madison Beth Weaver wanted to know if there was a way to predict who would benefit from Taxol and who might not, to spare these patients the side effects of the potent chemotherapy drug. Credit: UW Carbone Cancer Center Paclitaxel, or Taxol, is an old standby drug in the oncologist’s tool...